In Vitro Assessment of Injectable Bone Marrow Aspirate Concentrates Compared to Injectable Platelet-Rich Fibrin
Tissue Engineering and Regenerative Medicine · 2024
DOI: 10.1007/s13770-024-00677-7 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Tissue Engineering and Regenerative Medicine, 2024. Verfasst von Masako Fujioka-Kobayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20, Fujimi, Chiyoda-ku, Tokyo, 102…. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Gingiva, Osteoblasts, Fibroblasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Takeda Science Foundation, Shimane University.
Abstract (Originalsprache)
BACKGROUND: Injectable platelet-rich fibrin (iPRF), a liquid form of PRF that is prepared from peripheral blood without anticoagulants, promotes tissue wound healing and regeneration. The present study focused on iPRF-like bone marrow aspirate concentrate (iBMAC) prepared without anticoagulant, and the regenerative potential of iPRF and iBMAC was compared in vitro . METHODS: iPRF and iBMAC were prepared from the same New Zealand white rabbits. The cytocompatibility and regenerative potential of each concentrate were evaluated using primary rabbit gingival fibroblasts and osteoblasts. RESULTS: Both gingival fibroblasts and osteoblasts treated with each concentrate exhibited excellent cell viability. Interestingly, compared to cells treated with iPRF, cells treated with iBMAC demonstrated significantly greater migration potential. Furthermore, higher mRNA levels of transforming growth factor-β (TGF-β), vascular endothelial growth factor (VEGF), and collagen I (COL1) were observed in gingival fibroblasts treated with iBMAC than in those treated with iPRF. Compared with osteoblasts treated with iPRF, osteoblasts treated with iBMAC exhibited greater differentiation potential, as indicated by increased osteocalcin (OCN) expression and mineralization capability. CONCLUSION: The results of the in vitro study suggest that, compared with iPRF, iBMAC may promote wound healing and bone regeneration more effectively. However, further preclinical and clinical studies are needed to confirm the regenerative potential of iBMAC in the body.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20, Fujimi, Chiyoda-ku, Tokyo, 102-8159, Japan. masako@med.shimane-u.ac.jp.
- Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Shimane University, 89-1, Enya-cho, Izumo, Shimane, 693-8501, Japan. masako@med.shimane-u.ac.jp.
- Department of Oral and Maxillofacial Surgery, School of Life Dentistry at Tokyo, The Nippon Dental University, 1-9-20, Fujimi, Chiyoda-ku, Tokyo, 102-8159, Japan.
ORCID-Profile: Masako Fujioka-Kobayashi
Förderung
- Takeda Science Foundation
- Shimane University
Zitieren
APA
Fujioka-Kobayashi, M., Koyanagi, M., Inada, R., Miyasaka, A., & Satomi, T. (2024). In Vitro Assessment of Injectable Bone Marrow Aspirate Concentrates Compared to Injectable Platelet-Rich Fibrin. Tissue Engineering and Regenerative Medicine. https://doi.org/10.1007/s13770-024-00677-7
Vancouver
Fujioka-Kobayashi M, Koyanagi M, Inada R, Miyasaka A, Satomi T. In Vitro Assessment of Injectable Bone Marrow Aspirate Concentrates Compared to Injectable Platelet-Rich Fibrin. Tissue Engineering and Regenerative Medicine. 2024. doi:10.1007/s13770-024-00677-7
BibTeX
@article{FujiokaKobayashi2024,
author = {Fujioka-Kobayashi, Masako and Koyanagi, Masateru and Inada, Ryo and Miyasaka, Ayako and Satomi, Takafumi},
title = {In Vitro Assessment of Injectable Bone Marrow Aspirate Concentrates Compared to Injectable Platelet-Rich Fibrin},
journal = {Tissue Engineering and Regenerative Medicine},
year = {2024},
doi = {10.1007/s13770-024-00677-7}
}
EUVIMED